Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Sales (2016 - 2019)

Phio Pharmaceuticals' Return on Sales history spans 8 years, with the latest figure at 427.95% for Q4 2019.

  • For Q4 2019, Return on Sales fell 37462.0% year-over-year to 427.95%; the TTM value through Dec 2019 reached 427.95%, down 37462.0%, while the annual FY2024 figure was 29.55%, 117312.0% up from the prior year.
  • Return on Sales reached 427.95% in Q4 2019 per PHIO's latest filing, down from 383.1% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 26.19% in Q3 2018 to a low of 1358.11% in Q1 2017.
  • Average Return on Sales over 5 years is 272.06%, with a median of 184.69% recorded in 2015.
  • Peak YoY movement for Return on Sales: plummeted -113501bps in 2017, then surged 126076bps in 2018.
  • A 5-year view of Return on Sales shows it stood at 300.62% in 2015, then crashed by -57bps to 473.37% in 2016, then soared by 72bps to 133.47% in 2017, then soared by 60bps to 53.33% in 2018, then plummeted by -702bps to 427.95% in 2019.
  • Per Business Quant, the three most recent readings for PHIO's Return on Sales are 427.95% (Q4 2019), 383.1% (Q3 2019), and 95.19% (Q2 2019).